MORGAN STANLEY - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 37 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$420,845
+402.4%
711,969
+231.3%
0.00%
Q4 2022$83,767
-83.2%
214,901
-77.0%
0.00%
Q3 2022$498,000
-64.5%
933,572
+5.3%
0.00%
Q2 2022$1,402,000886,7160.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,500,419$1,754,2630.26%
Virtu Financial LLC 188,075$730.01%
ACADIAN ASSET MANAGEMENT LLC 899,514$3490.00%
Renaissance Technologies 1,208,224$4710.00%
TWO SIGMA SECURITIES, LLC 55,484$21,6280.00%
JPMORGAN CHASE & CO 49,656$190.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,159$140.00%
Gradient Investments LLC 63$250.00%
Allworth Financial LP 1,000$3900.00%
VANGUARD GROUP INC 974,996$380,0530.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders